Teratogenic Medications in Pregnancy: Core List | MDster You are offline Back online! [ MDster home ](/ "MDster home") Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) Menu Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) [ Login ](https://mdster.com/auth/login) 1. [ Home ](https://mdster.com) 2. [ Blog ](https://mdster.com/blog) 3. [ Medical Education ](https://mdster.com/blog?category=medical-education) 4. Teratogenic Medication Classes in Pregnancy: Core OB/GYN List [ Medical Education ](https://mdster.com/blog?category=medical-education) Teratogenic Medication Classes in Pregnancy: Core OB/GYN List =============================================================== A high-yield, clinically practical guide to the drug exposures that should make every obstetrician pause. [ MDster Editorial Team ](https://mdster.com/about) · May 12, 2026 · 5 min read · 194 [ Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) | [Corrections Policy](https://mdster.com/corrections) [ Obstetrics & Gynecology ](https://mdster.com/blog?tag=obstetrics-gynecology) [ OBGYN Boards ](https://mdster.com/blog?tag=obgyn-boards) [ High-Risk Pregnancy ](https://mdster.com/blog?tag=high-risk-pregnancy) [ Pharmacology ](https://mdster.com/blog?tag=pharmacology) [ Medication Safety ](https://mdster.com/blog?tag=medication-safety) [ Teratology ](https://mdster.com/blog?tag=teratology) ![Teratogenic Medication Classes in Pregnancy: Core OB/GYN List](https://mdster.com/storage/blog/images/teratogenic-medication-classes-in-pregnancy-core-obgyn-list.jpg) Share this article Share this post On this page 1. [ The Mental Model: Teratogen vs Fetotoxin ](#the-mental-model-teratogen-vs-fetotoxin) 2. [ ACE Inhibitors and ARBs: The Oligohydramnios Trap ](#ace-inhibitors-and-arbs-the-oligohydramnios-trap) 3. [ Methotrexate and Folate Antagonists: Respect the Folate Pathway ](#methotrexate-and-folate-antagonists-respect-the-folate-pathway) 4. [ Retinoids, Valproate, and Warfarin: The Pattern-Recognition List ](#retinoids-valproate-and-warfarin-the-pattern-recognition-list) 5. [ Lactation: Do Not Confuse Teratogenicity with Breast Milk Risk ](#lactation-do-not-confuse-teratogenicity-with-breast-milk-risk) 6. [ Key Takeaways ](#key-takeaways) 7. [ Conclusion ](#conclusion) 8. [ Frequently Asked Questions ](#blog-faqs) 9. [ References ](#references-heading) On this page 1. [ The Mental Model: Teratogen vs Fetotoxin ](#the-mental-model-teratogen-vs-fetotoxin) 2. [ ACE Inhibitors and ARBs: The Oligohydramnios Trap ](#ace-inhibitors-and-arbs-the-oligohydramnios-trap) 3. [ Methotrexate and Folate Antagonists: Respect the Folate Pathway ](#methotrexate-and-folate-antagonists-respect-the-folate-pathway) 4. [ Retinoids, Valproate, and Warfarin: The Pattern-Recognition List ](#retinoids-valproate-and-warfarin-the-pattern-recognition-list) 5. [ Lactation: Do Not Confuse Teratogenicity with Breast Milk Risk ](#lactation-do-not-confuse-teratogenicity-with-breast-milk-risk) 6. [ Key Takeaways ](#key-takeaways) 7. [ Conclusion ](#conclusion) 8. [ Frequently Asked Questions ](#blog-faqs) 9. [ References ](#references-heading) Every prenatal intake has a hidden board question: “Which medication on this list can injure the fetus, and when?” Miss that lisinopril at 24 weeks or valproate in a patient planning pregnancy, and you have not made a paperwork error—you have missed preventable fetal harm. As of May 2026, do not lean on old FDA A/B/C/D/X categories; use the **Pregnancy and Lactation Labeling Rule** framework, timing of exposure, dose, indication, and safer alternatives. The Mental Model: Teratogen vs Fetotoxin ---------------------------------------- Always date the exposure. Classic teratogenesis usually matters most during organogenesis, roughly **5–10 gestational weeks** by LMP dating. Fetotoxicity can occur later when a medication disrupts fetal physiology rather than early pattern formation. That distinction is why **ACE inhibitors and ARBs** are tested differently from isotretinoin or valproate. First-trimester ACE inhibitor exposure is not managed like isotretinoin exposure. The high-yield danger is **second- and third-trimester blockade of the fetal renin–angiotensin system**, causing renal hypoperfusion, oligohydramnios, pulmonary hypoplasia, hypocalvaria, neonatal renal failure, and fetal death. > **Clinical Pearl:** Date the exposure before naming the defect. ACE inhibitors and ARBs are mainly later-pregnancy renal fetotoxins; methotrexate, retinoids, valproate, and warfarin are classic organogenesis hazards. ACE Inhibitors and ARBs: The Oligohydramnios Trap ------------------------------------------------- If a patient becomes pregnant on lisinopril, losartan, valsartan, or similar agents, stop the drug promptly and transition to a pregnancy-compatible antihypertensive such as **labetalol, nifedipine ER, or methyldopa**, depending on comorbidities. Do not leave the patient untreated; uncontrolled chronic hypertension also causes placental and maternal morbidity. For exams, remember the sequence: fetal renal injury leads to **decreased fetal urine**, which leads to **oligohydramnios**, which leads to **pulmonary hypoplasia and deformational effects**. If exposure occurred after the first trimester, order targeted ultrasound assessment of anatomy, kidneys, bladder, growth, and amniotic fluid, and involve MFM. Methotrexate and Folate Antagonists: Respect the Folate Pathway --------------------------------------------------------------- Methotrexate is a folate antagonist used in oncology, autoimmune disease, and—deliberately—in ectopic pregnancy management. The nuance matters: methotrexate is appropriate for selected ectopic pregnancies, but it is contraindicated for a viable intrauterine pregnancy. Inadvertent first-trimester exposure raises concern for **craniofacial, limb, skeletal, cardiac, and growth abnormalities**, with possible developmental sequelae. The practical move is not panic; it is exposure dating, dose assessment, medication discontinuation when appropriate, folate counseling, and targeted imaging. Also remember that trimethoprim, pyrimethamine, and some antiepileptics have antifolate effects, though methotrexate is the prototype. Board pitfall: after methotrexate for ectopic pregnancy, counsel about delaying conception according to local protocol and the prescribing label, and restart folic acid once treatment is complete and hCG follow-up is appropriate. Retinoids, Valproate, and Warfarin: The Pattern-Recognition List ---------------------------------------------------------------- These are the medications boards love because each has a memorable fetal pattern. Drug classClassic fetal concernExam clue**Systemic retinoids**Craniofacial, cardiac, CNS, thymic, and ear anomaliesIsotretinoin for acne; iPLEDGE; avoid pregnancy**Valproate**Neural tube defects, cardiac/orofacial defects, neurodevelopmental impairmentHighest-yield antiepileptic teratogen**Warfarin**Nasal hypoplasia, stippled epiphyses, fetal bleeding/CNS injuryMechanical valve anticoagulation dilemma For retinoids, separate systemic from topical. **Isotretinoin** is a major teratogen: stop immediately if pregnancy occurs, refer for teratology/MFM counseling, and remember the prevention system—pregnancy testing and reliable contraception before, during, and after therapy. **Acitretin** deserves special respect because pregnancy avoidance is prolonged after discontinuation. For epilepsy, never casually stop antiseizure medication in pregnancy; maternal tonic-clonic seizures can be catastrophic. But do plan preconception. Current AAN/AES/SMFM guidance favors **lamotrigine or levetiracetam when clinically appropriate** and says to avoid **valproic acid** when feasible because of major congenital malformations, neural tube defects, lower IQ, and autism-spectrum risk. Use folic acid, but do not pretend folate eliminates valproate risk. Warfarin crosses the placenta; heparins do not. For most VTE indications in pregnancy, **LMWH is preferred**. The exception that creates real clinical tension is the patient with a mechanical heart valve, where maternal thrombosis risk may make anticoagulation decisions complex. That patient belongs in a multidisciplinary cardio-obstetrics/MFM plan, not a routine prenatal slot. Lactation: Do Not Confuse Teratogenicity with Breast Milk Risk -------------------------------------------------------------- Teratogenicity is about embryonic or fetal development, not breastfeeding by default. Warfarin is generally compatible with lactation. Valproate usually transfers into milk at low levels, with infant monitoring for hepatic symptoms. Methotrexate depends on dose and indication; high-dose therapy is avoided, while low-dose use requires individualized counseling. Isotretinoin is generally avoided during breastfeeding because data are limited and safer acne options exist. Key Takeaways ------------- - **ACE inhibitors and ARBs** are most dangerous in later pregnancy: think fetal renal failure and oligohydramnios. - **Methotrexate** is the prototype folate antagonist; confirm pregnancy location and viability before use. - **Systemic retinoids** require aggressive pregnancy prevention and immediate discontinuation if pregnancy occurs. - **Valproate** is the antiepileptic to avoid when feasible; do not abruptly stop seizure therapy without neurology input. - **Warfarin** causes classic embryopathy and fetal bleeding; LMWH is preferred for most pregnancy anticoagulation. - Always document exposure timing, dose, indication, counseling, and the safer replacement plan. Conclusion ---------- The core teratogen list is not trivia—it is prenatal risk prevention. Build the habit: reconcile medications early, date the exposure, protect maternal disease control, and escalate quickly when a high-risk exposure is found. Frequently Asked Questions ---------------------------- ### Is first-trimester ACE inhibitor exposure an automatic indication for pregnancy termination? No. The strongest ACE inhibitor/ARB concern is later-pregnancy fetotoxicity. Stop the drug, switch therapy, date the exposure, and arrange appropriate ultrasound follow-up. ### Why is valproate considered worse than many other antiseizure medications? Valproate is strongly associated with major congenital malformations, neural tube defects, and adverse neurodevelopmental outcomes. Avoid it when clinically feasible, preferably through preconception planning. ### Can warfarin be used while breastfeeding? Yes, warfarin is generally considered compatible with breastfeeding because infant exposure through milk is very low. ### What should be done after inadvertent isotretinoin exposure in pregnancy? Stop isotretinoin immediately, confirm gestational age and exposure timing, and refer for MFM or teratology counseling with targeted fetal evaluation. References (6) ------------------ 1. 1. [ FDA Pregnancy and Lactation Labeling Resources ](https://www.fda.gov/drugs/labeling-information-drug-products/pregnancy-and-lactation-labeling-resources) 2. 2. [ MotherToBaby Fact Sheet: ACE Inhibitors ](https://mothertobaby.org/fact-sheets/ace-inhibitors-pregnancy/) 3. 3. [ MotherToBaby Fact Sheet: Methotrexate ](https://www.ncbi.nlm.nih.gov/books/NBK582834/) 4. 4. [ MotherToBaby Fact Sheet: Isotretinoin ](https://www.ncbi.nlm.nih.gov/books/NBK582775/) 5. 5. [ AAN/AES/SMFM Practice Guideline on Antiseizure Medication in Pregnancy, 2024 ](https://publications.smfm.org/publications/556-teratogenesis-perinatal-and-neurodevelopmental-outcomes-after-in-utero/) 6. 6. [ LactMed: Warfarin ](https://www.ncbi.nlm.nih.gov/books/NBK501137/) Keep going Build confidence in OB/GYN with focused practice -------------------------------------------------- - Labor & delivery + postpartum essentials - Gynecology, screening, and common procedures - Review weak topics and improve faster [ Start practicing ](https://mdster.com/user/dashboard) [ Explore Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features) No credit card required. Full access to all features\*. No commitment. Cancel anytime. \*AI SOE Examiner is limited to 10 cases monthly for Advanced & Bundle subscribers. Explore topics: [ # Obstetrics & Gynecology ](https://mdster.com/blog?tag=obstetrics-gynecology) [ # OBGYN Boards ](https://mdster.com/blog?tag=obgyn-boards) [ # High-Risk Pregnancy ](https://mdster.com/blog?tag=high-risk-pregnancy) [ # Pharmacology ](https://mdster.com/blog?tag=pharmacology) [ # Medication Safety ](https://mdster.com/blog?tag=medication-safety) [ # Teratology ](https://mdster.com/blog?tag=teratology) [ Back to all posts ](https://mdster.com/blog) Discussion () ----------------- Join the discussion [ Log in ](https://mdster.com/auth/login) or [ Sign up ](https://mdster.com/auth/register) No comments yet Be the first to share your thoughts! ![]() More in Medical Education ------------------------- [ See all ](https://mdster.com/blog?category=medical-education) [### Weaning and Extubation Readiness: ICU Ventilation Basics 3 min read Jun 26, 2026 ](https://mdster.com/blog/weaning-and-extubation-readiness-icu-ventilation-basics) [### Ultrasound Guidance Principles for Safer Central Venous Access 6 min read Jun 25, 2026 ](https://mdster.com/blog/ultrasound-guidance-principles-for-safer-central-venous-access) [### Interview Strategies for Malingering and Factitious Disorder 6 min read Jun 24, 2026 ](https://mdster.com/blog/interview-strategies-for-malingering-and-factitious-disorder) Related Posts ------------- [ ![Postpartum Breast Abscess: Drainage, Antibiotics, and Lactation](https://mdster.com/storage/blog/images/postpartum-breast-abscess-drainage-antibiotics-and-lactation.jpg) Case Discussion ### Postpartum Breast Abscess: Drainage, Antibiotics, and Lactation Manage lactational breast abscess with ultrasound-guided drainage, targeted antibiotics, lactation support, and a clear plan for persistent or recurrent masses. 5 min read 0 comments ](https://mdster.com/blog/postpartum-breast-abscess-drainage-antibiotics-and-lactation) [ ![Weaning and Extubation Readiness: ICU Ventilation Basics](https://mdster.com/storage/blog/images/weaning-and-extubation-readiness-icu-ventilation-basics.jpg) Medical Education ### Weaning and Extubation Readiness: ICU Ventilation Basics Learn a practical ICU approach to extubation readiness, including SBT interpretation, NIF and RSBI limits, and post-extubation HFNC or NIV support. 3 min read 0 comments ](https://mdster.com/blog/weaning-and-extubation-readiness-icu-ventilation-basics) [ ![Ultrasound Guidance Principles for Safer Central Venous Access](https://mdster.com/storage/blog/images/ultrasound-guidance-principles-for-safer-central-venous-access.jpg) Medical Education ### Ultrasound Guidance Principles for Safer Central Venous Access Learn high-yield ultrasound principles for central venous access: vessel identification, dynamic needle tip tracking, arterial puncture avoidance, and sterile technique. 6 min read 0 comments ](https://mdster.com/blog/ultrasound-guidance-principles-for-safer-central-venous-access) [ ![Interview Strategies for Malingering and Factitious Disorder](https://mdster.com/storage/blog/images/interview-strategies-for-malingering-and-factitious-disorder.jpg) Medical Education ### Interview Strategies for Malingering and Factitious Disorder Learn how to interview for suspected malingering or factitious disorder using collateral data, records review, and objective symptom validity testing. 6 min read 0 comments ](https://mdster.com/blog/interview-strategies-for-malingering-and-factitious-disorder) [ ![Lactation-Related Breast Conditions: Galactocele to Cancer](https://mdster.com/storage/blog/images/lactation-related-breast-conditions-galactocele-to-cancer.jpg) Medical Education ### Lactation-Related Breast Conditions: Galactocele to Cancer A focused OB-GYN guide to lactation-related breast masses, galactocele, subareolar abscess, and inflammatory breast cancer red flags for boards and call shifts. 6 min read 0 comments ](https://mdster.com/blog/lactation-related-breast-conditions-galactocele-to-cancer) [ ![Dysuria and UTI Syndromes: Cystitis, Pyelo, and Risk Flags](https://mdster.com/storage/blog/images/dysuria-and-uti-syndromes-cystitis-pyelo-and-risk-flags.jpg) Medical Education ### Dysuria and UTI Syndromes: Cystitis, Pyelo, and Risk Flags A practical, board-focused guide to dysuria and UTI syndromes: distinguish cystitis from pyelonephritis, know when to culture, and treat risk flags safely. 5 min read 0 comments ](https://mdster.com/blog/dysuria-and-uti-syndromes-cystitis-pyelo-and-risk-flags) [ MDster home ](/ "MDster home") Master your medical exams with evidence-based learning. [ GET IT ON Google Play ](https://play.google.com/store/apps/details?id=com.mdster.app) Platform - [Home](https://mdster.com) - [Features](https://mdster.com/features) - [Pricing](https://mdster.com/pricing) - [About](https://mdster.com/about) Resources - [Blog](https://mdster.com/blog) - [Dashboard](https://mdster.com/user/dashboard) Support - [Contact](https://mdster.com/contact) - [Legal & Policies](https://mdster.com/legal) - [Medical Reviewers](https://mdster.com/medical-reviewers) © 2026 MDster [ ](https://play.google.com/store/apps/details?id=com.mdster.app) [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy) reCAPTCHA Protected by reCAPTCHA. Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply. Cookie Consent -------------- We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) & [ Privacy Policy ](https://mdster.com/privacy) Accept